Mackenzie Financial Corp Ngm Biopharmaceuticals Inc Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$0.6 - $1.31 $10,850 - $23,690	18,084 Added 40.29%	62,964 $54,000
Q3 2023 Oct 25, 2023	BUY	$1.05 - $3.37 $27,077 - $86,905	25,788 Added 135.07%	44,880 $48,000
Q2 2023 Aug 03, 2023	BUY	$2.44 - $4.53 $15,393 - $28,579	6,309 Added 49.35%	19,092 $49,000
Q1 2023 Apr 24, 2023	BUY	$3.72 - $5.4 $47,552 - $69,028	12,783 New	12,783 $52,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.